Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case-control study

被引:1
|
作者
Huang, Yichen [1 ]
Qiu, Yanran [1 ]
Xie, Zhijun [2 ]
Zhang, Fengqi [2 ]
Zhang, Yi [2 ]
Guan, Meihui [1 ]
Wang, Xinchang [1 ]
Cai, Wanru [1 ]
Sun, Jing [1 ]
机构
[1] Zhejiang Chinese Med Univ, Clin Coll 2, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China
关键词
Case-control study; Interstitial lung disease; Primary Sjogren syndrome; Risk factor; MORTALITY; CLASSIFICATION; UPDATE;
D O I
10.1007/s10067-023-06596-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the prevalence, clinical features, risk factors, and prognosis of interstitial lung disease (ILD) in patients with primary Sjogren's syndrome (pSS).Methods Data from 274 pSS patients from August 2013 to August 2022 were reviewed. The clinical features of pSS with ILD were revealed. Logistic regression was used to determine risk factors for ILD in pSS patients. Survival analysis and Cox regression were used to analyse the prognosis and prognostic factors of pSS patients.Results In pSS patients, the prevalence of ILD was 22.3% (61/274). The pSS patients with ILD were characterized by a late onset and long disease course, with a nonspecific interstitial pneumonia (NSIP) pattern as the predominant high-resolution computed tomography (HRCT) finding. Logistic regression results indicated that an age over 50 years old (OR 4.786, 95% CI 1.602-14.299; P = 0.005), purpuric rash (OR 4.695, 95% CI 1.537-14.339; P = 0.007), AMA-M2 antibody positivity (OR 2.582, 95% CI 1.166-5.722; P = 0.019), and diabetes (OR 2.514, 95% CI 1.025-6.167; P = 0.044) were risk factors for ILD in pSS patients. Cox regression results showed that advanced age (HR 1.240, 95% CI 1.088-1.413; P = 0.001) and cancer history (HR 8.411, 95% CI 1.771-39.934; P = 0.007) were risk factors for pSS patient survival.Conclusion This study showed that pSS patients with ILD tended to have a late onset and long course of pSS. An age over 50 years, purpuric rash, AMA-M2 antibody positivity, and diabetes were risk factors for ILD in pSS patients. Advanced age and cancer history were prognostic factors in pSS patients.
引用
收藏
页码:3033 / 3041
页数:9
相关论文
共 50 条
  • [21] Fibrotic or nonfibrotic interstitial lung disease in patients with primary Sjogren syndrome
    Luppi, Fabrizio
    Ferrara, Giovanni
    Faverio, Paola
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (02):
  • [22] TREATMENT OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH PRIMARY SJOGREN SYNDROME: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
    Lan, T. Y.
    Huang, H. T.
    Kao, J. H.
    Cheng, C. F.
    Lu, C. H.
    Shen, C. Y.
    Li, K. J.
    Hsieh, S. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 599 - 599
  • [23] Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study
    Weng, Chenghua
    Ding, Zongnan
    Zhou, Yiqun
    Yang, Qinyi
    Xue, Leixi
    Zhang, Lei
    Wang, Gang
    Liu, Zhichun
    RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 635 - 648
  • [24] Fibrotic Risk Factors in Primary Sjogren's Syndrome-associated Interstitial Lung Disease: A Observational Cohort Study
    Meng, W.
    Chen, X.
    Xie, B.
    Yang, X.
    Dai, H.
    Wang, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [25] Prognostic factors of interstitial lung disease associated with primary Sjogren's syndrome
    Enomoto, Yasunori
    Takemura, Tamiko
    Iwasawa, Tae
    Fukuda, Yuh
    Yanagawa, Noriyo
    Sakai, Fumikazu
    Baba, Tomohisa
    Hagiwara, Eri
    Ogura, Takashi
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [26] FIBROSING INTERSTITIAL LUNG DISEASE IN PRIMARY SJOGREN SYNDROME
    Manfredi, A.
    Vacchi, C.
    Della Casa, G.
    Cerri, S.
    Di Cecco, G.
    Coppi, F.
    Luppi, F.
    Salvarani, C.
    Sebastiani, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1508 - 1508
  • [27] Fibrosing interstitial lung disease in primary Sjogren syndrome
    Manfredi, Andreina
    Vacchi, Caterina
    DellaCasa, Giovanni
    Cerri, Stefania
    Cassone, Giulia
    Di Cecco, Giovanna
    Luppi, Fabrizio
    Salvarani, Carlo
    Sebastiani, Marco
    JOINT BONE SPINE, 2021, 88 (06)
  • [28] Interstitial lung disease in Primary Sjogren's syndrome
    Lin, Wei
    Xin, Zhifei
    Zhang, Jianlong
    Liu, Ning
    Ren, Xiuying
    Liu, Meilu
    Su, Yashuang
    Liu, Yixuan
    Yang, Liu
    Guo, Shaoying
    Yang, Yupeng
    Li, Yang
    Cao, Jingjing
    Ning, Xiaoran
    Li, Jingjing
    Xue, He
    Niu, Nannan
    Chen, Yingmin
    Li, Fang
    Sun, Lijun
    Zhang, Xiaopeng
    Zhang, Fengxiao
    Zhang, Wen
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [29] Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjogren's syndrome
    Lee, Kyung-Ann
    Nam, Bo Da
    Hwang, Jung Hwa
    Kim, Hyun-Sook
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] TREATMENT OF PRIMARY SJOGREN'S SYNDROME-RELATED INTERSTITIAL LUNG DISEASE: A RETROSPECTIVE COHORT STUDY
    Amlani, Barkha
    Elsayed, Ghada
    Barvalia, Umang
    Kanne, Jeffrey P.
    Meyer, Keith C.
    Sandbo, Nathan
    Li, Zhanhai
    McCoy, Sara S.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2020, 37 (02) : 136 - 147